chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive for Covid. Symptoms included fever of 102, severe joint pain, dry mouth, 3 and neuropathy.; Tested positive for Covid. Symptoms included fever of 102, severe joint pain, dry mouth, 3 and neuropathy.; severe joint pain; neuropathy; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2, on 29Dec2020 as dose 1, single (Batch/Lot number: unknown), in right arm, on 26Feb2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 21Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Systemic scleroderma" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing); "thyroiditis" (unspecified if ongoing). Concomitant medications included: CENTRIM; VITAMIN D [COLECALCIFEROL]; VITAMIN C [ASCORBIC ACID]; B-COMPLEX [VITAMIN B COMPLEX]; VITAMIN E [TOCOPHEROL]; CALCIUM VITAMIN C [ASCORBIC ACID; CALCIUM]; PROBIOTICS; HEMP SEED OIL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Tested positive for Covid. Symptoms included fever of 102, severe joint pain, dry mouth, 3 and neuropathy."; ARTHRALGIA (medically significant), outcome "unknown", described as "severe joint pain"; NEUROPATHY PERIPHERAL (medically significant), outcome "unknown", described as "neuropathy". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (30May2022) Negative; (31May2022) Negative; (01Jun2022) Negative; (02Jun2022) Negative; (03Jun2022) Negative; (04Jun2022) Positive; Body temperature: (unspecified date) 102. Therapeutic measures were taken as a result of drug ineffective, covid-19 included: full course of Paxlovid from 26May2022 to 30May2022. Clinical course: patient was tested positive for COVID-19 on unknown date. Symptoms included fever of 102, severe joint pain, dry mouth, 3 and neuropathy. Patient took full course of Paxlovid ending on a Monday (30May2022), tested negative. Felt great Mon (30May2022). and Tues (31May2022). Wed (01Jun2022), woke up feeling very fatigued, congested (head stuffed and chest congestion), experiencing neuropathy and joint pain, headache and stomach pain. Same on Thurs (02Jun2022), but also developed sore throat. Felt jittery and anxious and couldn't sleep. Tested negative Mon (30May2022)-Fri (03Jun2022) and Positive on Saturday (04Jun2022). No fever but had chills as well on Saturday (04Jun2022).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Allergic reaction; Starting with a rash on your neck. , Large mosquito bite now on the right side of my neck; I am still slightly itchy; Over the night swelling started and became worse just in the localized area on the back of my neck; Bumps and rash; This is a spontaneous report received from a non-contactable consumer (patient). A 28-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on an unspecified date (at the age of 28-years-old) as a single dose on the left side for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 as a single dose for COVID-19 immunization. On an unspecified date the patient experienced allergic reaction, rash on her neck, bumps and rash, itchy, and swelling. The events were reported as non-serious. The patient had an allergic reaction starting with a rash on her neck, "large mosquito bite" now on the right side of her neck. Today she was still slightly itchy but not as severe as yesterday. Over the night swelling started and became worse just in the localized area on the back of her neck. She was not sure if it was a lymph node. The patient received treatment with diphenhydramine (BENADRYL) one hour after the vaccine. The outcomes of allergic reaction and itchy were unknown. The outcome of bumps and rash was recovered. The outcome of swelling was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from registered nurse, concerning a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies were not provided. On 10-MAR-2014, the patient was vaccinated with a dose of LIQUID PEDVAQXHIB, 0.5 ml intramuscularly, (lot number and expiration date were not provided), which was exposed to a temperature of 47F for 10 minutes. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Tingling from his right shoulder to the fingers of the right arm; Recurring pain in his right arm exactly where he got the shot; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PARAESTHESIA (Tingling from his right shoulder to the fingers of the right arm) and VACCINATION SITE PAIN (Recurring pain in his right arm exactly where he got the shot) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 021B21A-1) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PARAESTHESIA (Tingling from his right shoulder to the fingers of the right arm) and VACCINATION SITE PAIN (Recurring pain in his right arm exactly where he got the shot). At the time of the report, VACCINATION SITE PARAESTHESIA (Tingling from his right shoulder to the fingers of the right arm) and VACCINATION SITE PAIN (Recurring pain in his right arm exactly where he got the shot) had not resolved.            No concomitant medications were reported.  No treatment medications were reported.
And redness/swelling of entire arm. Methylprednisolone 125 mg once, Cefazolin 2 gm once, prednisone as directed every day
Moderna COVID-19 Vaccine EUA  Seven days after the shot, had enormous "bug bite" at the site of the shot.  Measured roughly 2-3 inches in diameter (size of my palm).  Hard, warm and extremely itchy.   It eventually went away after 2-3 days.  Took Zyrtec and it seemed to help
Janssen COVID-19 Vaccine EUA Extreme dizziness leading to fainting five minutes after the shot. Blood pressure was extremely low for about 20 minutes after episode.  I?m 36 weeks and 3 days pregnant. Baby is expected on 04/10/2021.
Previously on 4/14, baby seen for runny nose and fever (T 100.3), chest clear, clear mucus from nose. On 4/15, presented with T 101.8, RR 76 positive retractions, wheezing all fields. Given Xopenex 0.63 via nebulizer with improvement. Transferred to hospital, then to another hospital. Diagnosis respiratory distress in critical care service Believed to have viral pneumonitis with evidence of laryngotracheobronchitis. Discharged with significant amounts of bronchodilator prescription for 2 days.
On 5/26/2016 he had an urgent care visit.  CHIEF COMPLAINT: Urgent care appointment. The patient received a PneumoVax injection on  5/24/2016 into his right deltoid. Approximately 12 hours later he called c/o redness, swelling and soreness near the injection site. My associate  instructed him to take Benadryl and Aleve. He took 2 doses of Benadryl and he has not noticed any significant improvement. The area of redness has progressed down his right bicep to the elbow. He denies fever, nausea, vomiting or soa.
Moderna booster of 0.25ml administered to pt out of a vial that was opened >12 hours. Vial was opened for approx. 24 hours but remained in the stable temperature of 4-5 degrees Celsius. No adverse reaction noted
Pt developed a large lump in area of PROQUAD injection. Sz of a large ball with warmth et redness.
experienced "a little pain" in her shoulder that day and the next morning; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported), via an unspecified route of administration on an unspecified date as first dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced "a little pain" in her shoulder that day of the vaccination and the next morning. The patient would like to know who like to know how effective her first dose of the BNT162B2 vaccine was. Caller was concerned about the amount of protection she had against COVID-19 now that she has had her first dose because she was supposed to go for an eye  appointment next Thursday (as reported) and was concerned being around a bunch of people. Caller states that her brother states it's 20% or 40%, and also states that doctor said it was "more than that." Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a pharmacist via a company representative concerning a "few patients" (ages and genders not reported) who on an unknown date were vaccinated with a dose ZOSTAVAX (dose not reported). The pharmacist reported that the "few patients" had developed a red area (without pain, itching or rash) at the ZOSTAVAX injection site. Patients outcome of red area at injection site was not reported. Relationship between red area at injection site and therapy with ZOSTAVAX was not reported. Additional information is not expected.
This initial spontaneous report was received from a Licensed Practical Nurse, concerning to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication, concurrent conditions or drug allergies/drug reactions described. On an unknown date, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) injection (lot # K020760 with expiration date 31-OCT-2016; dose and route were not reported). The vaccine was exposed to temperature of 24.80 degrees F for 45 minutes. There was no previous temperature excursion. No adverse effects were reported. It was unknown if the patient sought medical attention. A product quality complaint (PQC) was not involved. Additional information has been requested.
I had swelling, redness and soreness for the 1st 3 days after getting the vaccine but went away. Yesterday, 1/14/21(9days after receiving the vaccine), I noticed that my arm was itching where I received the vaccine and when I looked it was all red and swollen. Not having any pain and have had no other reactions to the vaccine. I am scheduled February 2nd for my 2nd vaccine. Will it be okay to receive it?
J96.00 ACUTE RESPIRATORY FAILURE 1/19/2022 COVID-19 PNEUMONIA
pt recv vax; fever; apapjerky movements, sz per mom;to er; T 103; dx as ear  infect; started Meds; to f/u w/in 10 days;
Near full body rash a few days after second vaccination.  I believe my current symptoms, which are compatible with symptoms of transverse myelitis began probably in November and continue to date.  I did not record any dates including the beginning of the rash, which went away probably after a 2 week period.  I have had extreme pain in my right leg for the first 2 days that lasted for a short duration.  Pain in my knee, thigh, hip and right lower back have been constant and aggravated by walking or stretching to reach something.  The symptoms did subside for about 2 weeks or so and then returned.  I reported the rash to the hospital that administered the vaccination, however, I could only guess that my pain symptoms were related to the vaccine until I stumbled upon an article relating vaccine side effects with rare cases of transverse myelitis which appears to describe my symptoms.
Patient received first dose of Pfizer Covid-19 vaccine on Sept 3. She felt 'fine' after administration. On 9/13, patient fell unconscious TWICE in 5 minutes. She was brought into the Emergency Department and was found to have low blood pressure and blood sugar levels (both checked at home and at hospital). CT scan  was done - normal. Urine test showed blood and protein in the urine. MD followup for kidney/bladder on Oct 1. Patient has no history of diabetes, blood pressure (low or high). She considers herself healthy, no hx of 'blacking out.'
Chills, fever, muscle aches, tremors, extreme weakness (unable to stand), COVID arm
Patient received Moderna booster of 0.5mL instead of 0.25mL. Not adverse reaction reported after speaking with Wellness Director at the facility.
Given Tdap, MENACTRA & HPV on 10/9/12 started with swelling of Lt arm & headache yesterday. As per mother better today.
pt recv vax & 48hr p/vax devel flu, rash, pruritus, t101.4;
3 months after my second vaccine my ME/CFS and fibromyalgia were much worse. I lost tons of hair, my entire body hurt, arthritis everywhere, fingernails stopped growing...This is since June 2 or 3, but I have been worse and in hindsight and in checking with other ME/CFS health sites, patients have experienced the same thing. Worsening-long term flares. Brain fog is much worse.
pt recvd vax 9AUG94 & noc of 29AUG94 devel t102; morning of 30AUG94 devel swelling of rt parotid gland;
Excessive thirst after both vaccines, just after second vaccine, face becoming bright red and blood pressure low, two days after second vaccine, unable to sleep, passed out when standing up X 1, nausea, fatigue
Pt c/o dizzy and sweaty. Vital signs 140/70, HR 67, spO2 98%. Pt is diabetic, has glucometer in car. Pt wanted to leave.
Since I got the vaccine not the day of but days after I started getting very severe migraines. I've had them every single day since the vaccine. I had to send the  doctor a request to fill an old prescription for the headaches that is not really helping. I've had migraines before but I haven't had a migraine since 2016. My brain feels like swollen and like its flipping. Not a dizzy feeling but a feeling like my brain is doing a cartwheel in my head.
After not having my menstrual cycle for one year and six months , due to menopause. I begsn to get some spotting after i received my COVID-19 vaccination. On march 31, 2021 and continued for a month. It went from light to medium for a week and then to light for about two weeks. Today 4/28/2021 it is finally gone .
1FEB97 temp 100.2, loose cough, malaise;4FEB97 recv flu vax;given med;
on the day of vax arm, was stinging day of vax;pt started w/inc temp which lasted 2 dasy;seconday p/vax pt c/o chills, dry mouth, inc temp, & swelling of the arm where vax was recv;rt upper arm puffy, warm;
Diarrhea, vomiting, shakes, body aches came on about 4 1/2hr. after injection lasted for about 14hrs.
Temperature 102.3, chills - Ibuprofen - lasted 8 hours Nausea - rest - lasted 8 hours Light-headed - passed out in hallway at home, hit wall (made hole through drywall), 5-10 minute duration, unable to get up (crawled back to bed)
Patient's mother reported that her daughter's right upper arm was swollen and hot near the site of the SC ProQuad injection; redness was in the shape of a triangle. Left deltoid distal to injection sites of polio and DTaP injections also became red and swollen on morning of 8/14/15. Mother noted that child was "normal--she's herself." Mother mentioned the clinic the family attends so I called that clinic to ask if patient could come in; clinic encouraged patient to come in. Mother reported on 8/17/15 that she had taken her daughter to clinic on 8/14/15 where topical ointment and liquid antihistamine were prescribed. Mother reported on 8/17/15 that her daughter was "doing good" and "rashes are going away."
mild macular rash w/central vesicles on trunk & face over the last 24hr, no other s/s of illness;
I did not have an adverse reaction to the vaccine.  I started feeling symptoms 01/01/2023 with a cough and runny nose. I was cold and could not get warm, but I had no fever. Progressively my joints hurt, and I got out of breath really easy. I tested positive for COVID-19 on 01/06/2023. I contacted my doctor on 01/06/2023 and got a prescription for Paxlovid that day. I tolerated the medication without any trouble. As of today, I still have the joints pain and shortness of breath.
8 days after injection, right arm started to get red, swollen and hot at injection site.  This spread around upper arm area through the day.  Overnight I experienced body aches and chills.  Those flu like symptoms lasted just under 24 hours.  The arm was still swollen and red and hot for the next two days.  All those symptoms decreased.  The swelling and hotness disappeared completely.  The arm is still red in some areas and it is itchy sometimes.  Today one week after the delayed reaction, my arm still has red areas and its very itchy today.
I had a light headache on Tuesday night; by Wednesday night I started to run a temp of 101. This put me in bed for a couple of days. Thursday I had swelling and pain in my left arm. It felt like it was under my arm. I had a talk with my doctor and they provided me some medicine Ondansetron HCl for nausea, and Tylenol. I was throwing up and stomach complication.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Nausea-Medium
Immediately after receiving the Fluviron, she fainted and hit her head on the floor.
Time 9:00am on 3-20-12 Dizzy, vision, headache, fever, tiredness, felt lightheaded. Just gave TYLENOL symptoms subside on 3-21-12.
got it anyway, very frustrating; Initial information received on 20-Dec-2022 regarding an unsolicited valid social media non-serious case received from a consumer/non-healthcare professional (hcp).  This case involves an unknown age and unknown gender patient who got it anyway, very frustrating after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date in early Oct-2022, the patient Got shot of INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, dose: unknown) (lot number and expiry date: not reported) via unknown route in unknown administration site for Prophylactic vaccination.  On an unknown date, the patient developed a non-serious event of got it anyway, very frustrating (frustration tolerance decreased) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events. It is unknown if the patient had any medical history, concomitant disease, or risk factor. It is unknown if there were lab data/results available.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (got it anyway, very frustrating).  At time of reporting, the outcome was Unknown.
Had to wait a month between shots; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too short in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date). Concomitant products included SHINGLES VACCINE (NOS) (SHINGLES VACCINE).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced drug dose administration interval too short (Verbatim: Had to wait a month between shots). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 15-MAR-2023 The case was received from the patient interactive digital media. The patient stated that he/she only had to wait a month between shots. The follow-up could not be possible as no contact details were available. The patient received 2nd dose of Shingles vaccine, later than the recommended interval, which led to lengthening of vaccination schedule. This case is linked with US2023AMR047845, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR047845:Same reporter
"Hot flashes", nausea, dizzy, tingling lips, chest pain, difficulty breathing. Went to the emergency room. She states she waited in the lobby for several hours and left because chest pains resolved. She states she went home and took 3 Benadryl 25mg by mouth. Currently has headache, dizzy, nausea, and feeling of heat.
Dose administered intradermally instead of SQ (Patient is 17  years of age)
Patient received a dose of Moderna vaccine when she was fully vaccinated with Pfizer.   She answered the following question with with the answer no.   Have you received a vaccine in the last two weeks? This was a deceptive response There was no physical manifestation of issues/side effects.  .
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) at the right triceps. At an unspecified interval after zoster vaccination the patient developed a large area of erythema and perhaps a lesser area of induration. The erythema was somewhat lower than the shoulder and somewhat higher than the elbow. At the time of this report the patient's outcome was unknown. Follow up information has been received from the physician concerning the 61 year old female patient with no illness at the time of vaccination who on 22-OCT-2010 (at 14:30) was vaccinated subcutaneously into the right arm with the first dose of ZOSTAVAX (Merck) (Lot # 665527/0696Z). The physician reported that after receiving the vaccine on an unspecified date, the patient experienced severe redness and irritation at site of injection, swelling from shoulder to elbow, heat noticed about 15 cm temp of 101.4, severe headache and malaise. It was reported that it was daily progression of inflammation until 27-OCT-2010, but the physician could not see progression from 26-OCT-2010, probably it was beginning to subside. The erythema extended but the induration was somewhat less, on 27-OCT-2010 was better. At the exact injection site there was a nodular area deeper in the arm that was tender that suggested a fluid collection or abscess possibly. The patient had fever elevation to 101.4 on 25-OCT-2010 then to 100.4 each day until 27-OCT-2010. The patient was still feeling sick. On 29-OCT-2010 the physician reported that on an unspecified date all the warmth and erythema were gone and the induration had subsided to about 3-5 cm around the injection side, tenderness was also much better, her skin had more of a look of darkened sunburn but no desquamation. In addition to the reaction in the arm, however she also had marked flu like symptoms with fever to 101.4, severe malaise, anorexia, marked headache. She was in bed for almost four days. As of 29-OCT-2010 the arm was as described above but the flu type symptoms were still present but improved. The patient sought unspecified medical attention. No further information is available.
From initial information received on 11JUL2003 from a registered nurse , it was reported that a 58 year old female patient received her third dose of IMOVAX rabies as part of a post exposure series, lot number W0136, administered intra-muscularly in the right deltoid on 09JUL2003. The patient had received two previous doses of IMOVAX after being bitten y a rabid skunk. The day she received the third dose of IMOVAX, the patient experienced stomach cramps, nausea, vomiting, headache, joint weakness and dizziness. The patient's recovery status was not reported.